Carregant...
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...
Guardat en:
Autors principals: | , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
MDPI AG
2019-10-01
|
Col·lecció: | Cancers |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2072-6694/11/10/1584 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|